EU Hedge: Pharmion and Celgene

By admin | January 31, 2008
Rating 3.00 out of 5
[?]

Submitted by BioHealth Investor, CLSDF

A very interesting few days for Pharmion (NASDAQ: PHRM) and Celgene (NASDAQ: CELG) and how they are faring in their product approval efforts in Europe.

More Here>

Comments